Aptamers targeting RNA molecules
- PMID: 19377979
- DOI: 10.1007/978-1-59745-557-2_6
Aptamers targeting RNA molecules
Abstract
Oligonucleotides complementary to RNA sequences interact poorly with folded target regions. In vitro selection of oligonucleotides carried out against RNA structures have led to aptamers that frequently differ from antisense sequences, but rather take advantage of non-double-stranded peculiarities of the target. Studies along this line provide information about tertiary RNA architectures as well as their interaction with ligand of interest. We describe here a genomic SELEX approach and its application to the recognition of stem-loop structures prone to the formation of kissing complexes. We also provide technical details for running a procedure termed 2D-SELEX that takes advantage of both in vitro selection and dynamic combinatorial chemistry. This allows selecting aptamer derivatives containing modified nucleotides that cannot be incorporated by polymerases. Last we present in vitro transcription conditions under which large amounts of RNA, suitable for NMR structural studies, can be obtained. These different aspects of the SELEX technology have been applied to the trans-activating responsive element of the human immunodeficiency virus type 1, which is crucial for the transcription of the retroviral genome.
Similar articles
-
LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1.Blood Cells Mol Dis. 2007 May-Jun;38(3):204-9. doi: 10.1016/j.bcmd.2006.11.008. Epub 2007 Feb 14. Blood Cells Mol Dis. 2007. PMID: 17300966
-
Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions.Methods Mol Biol. 2011;764:279-300. doi: 10.1007/978-1-61779-188-8_19. Methods Mol Biol. 2011. PMID: 21748648
-
NMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA-modified aptamer.Nucleic Acids Res. 2007;35(18):6103-14. doi: 10.1093/nar/gkm655. Epub 2007 Sep 3. Nucleic Acids Res. 2007. PMID: 17768146 Free PMC article.
-
[Aptamers: selection and scope of applications].Pathol Biol (Paris). 2006 May;54(4):251-8. doi: 10.1016/j.patbio.2006.03.002. Epub 2006 May 5. Pathol Biol (Paris). 2006. PMID: 16678359 Review. French.
-
Regulating eukaryotic gene expression with aptamers.FEBS Lett. 2004 Jun 1;567(1):55-62. doi: 10.1016/j.febslet.2004.03.111. FEBS Lett. 2004. PMID: 15165893 Review.
Cited by
-
RNA modularity for synthetic biology.F1000Prime Rep. 2013 Nov 1;5:46. doi: 10.12703/P5-46. eCollection 2013. F1000Prime Rep. 2013. PMID: 24273647 Free PMC article. Review.
-
Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy.Small. 2019 May;15(22):e1900903. doi: 10.1002/smll.201900903. Epub 2019 Apr 26. Small. 2019. PMID: 31026116 Free PMC article.
-
Aptamers' Potential to Fill Therapeutic and Diagnostic Gaps.Pharmaceuticals (Basel). 2024 Jan 12;17(1):105. doi: 10.3390/ph17010105. Pharmaceuticals (Basel). 2024. PMID: 38256938 Free PMC article.
-
Identification of conserved RNA secondary structures at influenza B and C splice sites reveals similarities and differences between influenza A, B, and C.BMC Res Notes. 2014 Jan 9;7:22. doi: 10.1186/1756-0500-7-22. BMC Res Notes. 2014. PMID: 24405943 Free PMC article.
-
Non-coding landscapes of colorectal cancer.World J Gastroenterol. 2015 Nov 7;21(41):11709-39. doi: 10.3748/wjg.v21.i41.11709. World J Gastroenterol. 2015. PMID: 26556998 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources